{"recordsFiltered":50008,"recordsTotal":50008,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=45300","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=-completion_date&start=44700","results":[{"registry_id":"NCT06340568","publication_url":"https://clinicaltrials.gov/study/NCT06340568","title":"A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07075718","publication_url":"https://clinicaltrials.gov/study/NCT07075718","title":"Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","has_exemption":false,"start_date":"2025-06-12","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06951594","publication_url":"https://clinicaltrials.gov/study/NCT06951594","title":"Iowa Cochlear Implant Clinical Research Center Study on Robotic-Assisted Versus Manual Electrode Array Insertion","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07045909","publication_url":"https://clinicaltrials.gov/study/NCT07045909","title":"A Phase 2, Open-label, Multicenter Multi-cohort Study to Evaluate the Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"PETHEMA Foundation","sponsor_slug":"pethema-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06356155","publication_url":"https://clinicaltrials.gov/study/NCT06356155","title":"A Phase II, Open-label, Single-arm, Multi-center Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer (NEPTUNE)","has_exemption":false,"start_date":"2025-07-22","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan Rogel Cancer Center","sponsor_slug":"university-of-michigan-rogel-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06850805","publication_url":"https://clinicaltrials.gov/study/NCT06850805","title":"A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps","has_exemption":false,"start_date":"2025-07-28","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Optinose US Inc.","sponsor_slug":"optinose-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07070232","publication_url":"https://clinicaltrials.gov/study/NCT07070232","title":"A Phase I/II, Open-label, Adaptive Two-part Trial to Evaluate the Safety, Efficacy, Optimal Dose and Pharmacokinetics of BNT326 as Monotherapy and in Combination With Cancer Immunotherapies in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2025-08-12","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959524","publication_url":"https://clinicaltrials.gov/study/NCT06959524","title":"AGENT DCB STANCE: AGENT Drug-Coated Balloon for STent AvoidANCE in PCI for De Novo Coronary Artery Disease","has_exemption":false,"start_date":"2025-08-21","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07114380","publication_url":"https://clinicaltrials.gov/study/NCT07114380","title":"Investigation of Cold Snare Polypectomy for Removing 10-20 mm 0-Ip Colorectal Polyp: One Feasibility and Safety Study","has_exemption":false,"start_date":"2025-08-25","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"National Taiwan University Hospital","sponsor_slug":"national-taiwan-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07023835","publication_url":"https://clinicaltrials.gov/study/NCT07023835","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Usnoflast Administered to Adult Subjects With ALS","has_exemption":false,"start_date":"2025-09-17","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Zydus Therapeutics Inc.","sponsor_slug":"zydus-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07202884","publication_url":"https://clinicaltrials.gov/study/NCT07202884","title":"A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight","has_exemption":false,"start_date":"2025-09-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07181837","publication_url":"https://clinicaltrials.gov/study/NCT07181837","title":"A Multi-Center, Open-label, Phase 1/2 Trial of the Safety and Efficacy of MVX-220 Gene Therapy Administered by Intra-Cisterna Magna Injection to Participants With Angelman Syndrome","has_exemption":false,"start_date":"2025-10-29","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"MavriX Bio, LLC","sponsor_slug":"mavrix-bio-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06699121","publication_url":"https://clinicaltrials.gov/study/NCT06699121","title":"A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)","has_exemption":false,"start_date":"2025-11-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"LISCure Biosciences","sponsor_slug":"liscure-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07205601","publication_url":"https://clinicaltrials.gov/study/NCT07205601","title":"Phase 2a Assessment of Safety, Tolerability, and Efficacy of Repeated Dosing of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild to Moderate Alzheimer's Disease","has_exemption":false,"start_date":"2025-11-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Regeneration Biomedical, Inc.","sponsor_slug":"regeneration-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06917313","publication_url":"https://clinicaltrials.gov/study/NCT06917313","title":"A Randomized Phase II Study to Evaluate the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy","has_exemption":false,"start_date":"2025-12-05","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219602","publication_url":"https://clinicaltrials.gov/study/NCT07219602","title":"A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of Obicetrapib 10 mg and Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome (RUBENS Trial)","has_exemption":false,"start_date":"2025-12-11","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"NewAmsterdam Pharma","sponsor_slug":"newamsterdam-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06722183","publication_url":"https://clinicaltrials.gov/study/NCT06722183","title":"FUTURE Platform Trial - A Phase II Platform Trial of Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor Entities","has_exemption":false,"start_date":"2025-12-16","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","sponsor_slug":"institut-fur-klinische-krebsforschung-ikf-gmbh-at-krankenhaus-nordwest","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225712","publication_url":"https://clinicaltrials.gov/study/NCT07225712","title":"A Multicenter, Uncontrolled, Open-label Trial to Evaluate the Tolerability, Safety, and Efficacy of Long-term Administration of SEP-363856 in Patients With Schizophrenia","has_exemption":false,"start_date":"2025-12-22","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Co., Ltd.","sponsor_slug":"otsuka-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284979","publication_url":"https://clinicaltrials.gov/study/NCT07284979","title":"A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes","has_exemption":false,"start_date":"2025-12-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Kailera","sponsor_slug":"kailera","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07398417","publication_url":"https://clinicaltrials.gov/study/NCT07398417","title":"A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia","has_exemption":false,"start_date":"2026-01-14","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Axsome Therapeutics, Inc.","sponsor_slug":"axsome-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07183319","publication_url":"https://clinicaltrials.gov/study/NCT07183319","title":"Circulating Tumor DNA Response Adapted Treatment De-escalation Metastatic Urothelial Carcinoma (CT-READ)","has_exemption":false,"start_date":"2026-01-19","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258407","publication_url":"https://clinicaltrials.gov/study/NCT07258407","title":"A Phase 1/2 Dose Escalation Trial With Administration Schedule Exploration Evaluating Single Agent TD001, a PSMA-Targeted Antibody-Drug Conjugate, in Patients With PSMA-Expressing Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2026-01-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"T.O.A.D. Oncology SA","sponsor_slug":"toad-oncology-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04901741","publication_url":"https://clinicaltrials.gov/study/NCT04901741","title":"An Open-label Phase 2 Study of Olaptesed Pegol (NOX-A12) Combined With Pembrolizumab and Nanoliposomal Irinotecan/5-FU/Leucovorin or Gemcitabine/Nab-paclitaxel in Microsatellite-stable Metastatic Pancreatic Cancer Patients","has_exemption":false,"start_date":"2026-01-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"TME Pharma AG","sponsor_slug":"tme-pharma-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07322003","publication_url":"https://clinicaltrials.gov/study/NCT07322003","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis","has_exemption":false,"start_date":"2026-02-01","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Prilenia","sponsor_slug":"prilenia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321886","publication_url":"https://clinicaltrials.gov/study/NCT07321886","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes","has_exemption":false,"start_date":"2026-02-06","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07353931","publication_url":"https://clinicaltrials.gov/study/NCT07353931","title":"A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Osteoarthritis Knee Pain, and Obesity or Overweight (ENLIGHTEN-4)","has_exemption":false,"start_date":"2026-02-09","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07369011","publication_url":"https://clinicaltrials.gov/study/NCT07369011","title":"A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Moderate to Severe Obstructive Sleep Apnea, and Obesity or Overweight","has_exemption":false,"start_date":"2026-02-10","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07420283","publication_url":"https://clinicaltrials.gov/study/NCT07420283","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study With a Separate Open-label Cohort to Evaluate the Efficacy and Safety of Brenipatide as Adjunctive Treatment to Transmucosal Buprenorphine With or Without Naloxone in Early Recovery of Participants With Opioid Use Disorder (RENEW-Op-1)","has_exemption":false,"start_date":"2026-02-13","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06842498","publication_url":"https://clinicaltrials.gov/study/NCT06842498","title":"A Phase 2 Dose Optimization Trial Evaluating a CD46-Targeted Antibody-Drug Conjugate (FG-3246) in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2026-02-22","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Kyntra Bio","sponsor_slug":"kyntra-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287150","publication_url":"https://clinicaltrials.gov/study/NCT07287150","title":"A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy and Safety of the Combination of Inavolisib Plus Enzalutamide Versus Physician's Choice of ARPI or Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2026-03-11","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07477457","publication_url":"https://clinicaltrials.gov/study/NCT07477457","title":"OstEvo - Osteosarcoma Evolves","has_exemption":false,"start_date":"2026-03-11","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07542470","publication_url":"https://clinicaltrials.gov/study/NCT07542470","title":"Assessing Outcomes in Spinal Surgery Patients Who Receive Iceless Cryopneumatic Therapy Using the NICE1 Device as Compared to Standard of Care","has_exemption":false,"start_date":"2026-03-15","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Sarasota Memorial Health Care System","sponsor_slug":"sarasota-memorial-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07736937","publication_url":"https://clinicaltrials.gov/study/NCT07736937","title":"A Multicenter, Phase Ib/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Clinical Activity of TUB-040, in Combination With Standard Ovarian Cancer Drugs in Patients With High-grade Epithelial Serous or Endometrioid Epithelial Ovarian Cancer OC)","has_exemption":false,"start_date":"2026-03-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Tubulis GmbH","sponsor_slug":"tubulis-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339358","publication_url":"https://clinicaltrials.gov/study/NCT07339358","title":"Safety & Performance of the World Medica World Diverter Embolization Device","has_exemption":false,"start_date":"2026-03-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"World Medica USA, LLC","sponsor_slug":"world-medica-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07401290","publication_url":"https://clinicaltrials.gov/study/NCT07401290","title":"The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma","has_exemption":false,"start_date":"2026-03-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Vance Thompson Vision","sponsor_slug":"vance-thompson-vision","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07389031","publication_url":"https://clinicaltrials.gov/study/NCT07389031","title":"Maralixibat for the trEatment of inTrAhePatic cHOlestasis of pRegnancy (METAPHOR)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Imperial College London","sponsor_slug":"imperial-college-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432659","publication_url":"https://clinicaltrials.gov/study/NCT07432659","title":"Add-On Efficacy of Home-Based Transcutaneous Tibial Nerve Stimulation Via the ZIDA Control Sock in Adults With Overactive Bladder on Preexisting Stable Pharmacotherapy","has_exemption":false,"start_date":"2026-04-17","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07414745","publication_url":"https://clinicaltrials.gov/study/NCT07414745","title":"MDT-0123 Clinical Trial Targeting Patients Who Require Lumbar Vertebral Fusion in Japan","has_exemption":false,"start_date":"2026-04-24","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Spinal and Biologics","sponsor_slug":"medtronic-spinal-and-biologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07536269","publication_url":"https://clinicaltrials.gov/study/NCT07536269","title":"A Phase 2, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Crinecerfont in Pediatric Participants 3 Months to <4 Years of Age With Classic Congenital Adrenal Hyperplasia","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07614321","publication_url":"https://clinicaltrials.gov/study/NCT07614321","title":"Is Silodosin Effective for Treating Lower Urinary Tract Symptoms in Female Patients With Multiple Sclerosis? A Randomized Controlled Trial","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Atlantic Health System","sponsor_slug":"atlantic-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07602699","publication_url":"https://clinicaltrials.gov/study/NCT07602699","title":"A Multi-Site Trial of Tirzepatide for Smoking Cessation","has_exemption":false,"start_date":"2026-06-05","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07734415","publication_url":"https://clinicaltrials.gov/study/NCT07734415","title":"A Long-term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous IMG-007 in Participants of a Previous IMG-007 Moderate-To-Severe Atopic Dermatitis Clinical Trial","has_exemption":false,"start_date":"2026-06-05","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Inmagene LLC","sponsor_slug":"inmagene-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07568145","publication_url":"https://clinicaltrials.gov/study/NCT07568145","title":"PREVENT Study: Promoting Resilience Via Early Neurostimulation After Trauma","has_exemption":false,"start_date":"2026-06-18","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07585968","publication_url":"https://clinicaltrials.gov/study/NCT07585968","title":"Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Ablation Solutions","sponsor_slug":"medtronic-cardiac-ablation-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07663422","publication_url":"https://clinicaltrials.gov/study/NCT07663422","title":"GU-228: Mycophenolate Mofetil in Combination With Prednisone as First-line Treatment of Immune Related Hepatitis Resulting From Checkpoint Inhibitor Therapy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Fox Chase Cancer Center","sponsor_slug":"fox-chase-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227779","publication_url":"https://clinicaltrials.gov/study/NCT07227779","title":"A PHASE 2 NOVEL ANTIMICROBIAL COMBINATION THERAPY TO TREAT TUBERCULOUS MENINGITIS","has_exemption":false,"start_date":"2026-07-28","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"David Boulware","sponsor_slug":"david-boulware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06605651","publication_url":"https://clinicaltrials.gov/study/NCT06605651","title":"A Phase II Proof of Concept Multicenter, Randomized, Double-Blind Study to Assess the Safety and Efficacy of Phage Therapy in Patients With Hip or Knee Prosthetic Joint Infection Due to Staphylococcus Aureus Treated by DAIR","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Phagenix","sponsor_slug":"phagenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07431307","publication_url":"https://clinicaltrials.gov/study/NCT07431307","title":"A Two-part Phase IIb Randomized, Multicenter, Open-label Comparative Study to Firstly Evaluate the Safety and Efficacy Trial of BV100 in Combination With Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol Versus Best Available Therapy in Patients With Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia and Bloodstream Infection, Suspected or Confirmed to be Due to Carbapenem-resistant Acinetobacter Baumannii Calcoaceticus Complex (CRABC), and Secondly to Evaluate the Pharmacokinetics of BV100 in Combination With Low Dose Polymyxin B Plus Cefideroc","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"BioVersys AG","sponsor_slug":"bioversys-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07723248","publication_url":"https://clinicaltrials.gov/study/NCT07723248","title":"A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination With Darolutamide Compared With ARPI or Docetaxel in Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Abiraterone Acetate (Himalayas-1)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"ORIC Pharmaceuticals","sponsor_slug":"oric-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06137365","publication_url":"https://clinicaltrials.gov/study/NCT06137365","title":"A Randomized, Placebo-Controlled Clinical Trial of Once Daily Oral Cannabis for Weight Loss in Obese Individuals","has_exemption":false,"start_date":"2026-08-05","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Joshua A. Lile, Ph.D.","sponsor_slug":"joshua-a-lile-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07752979","publication_url":"https://clinicaltrials.gov/study/NCT07752979","title":"A Phase 2 Dose-Finding Study to Assess the Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities","has_exemption":false,"start_date":"2026-08-07","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07695558","publication_url":"https://clinicaltrials.gov/study/NCT07695558","title":"Post Market Study of the Flexagon Only System and Flexagon Plus OTOLoc for Creation of Side-to-Side Duodeno-Ileal Diversion & Flexagon Plus OTOLoc Self Forming Magnet (SFM) System for Creation of Side-to-Side Jejunum-Jejunum and Ileal-Ileal Anastomoses","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07143448","publication_url":"https://clinicaltrials.gov/study/NCT07143448","title":"Phase 1b/2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study Assessing the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HS235 Added to Background Treatment in Adults With PAH","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"35Pharma Inc","sponsor_slug":"35pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06899178","publication_url":"https://clinicaltrials.gov/study/NCT06899178","title":"A Phase 2, Double Blind, Randomized, Placebo-controlled Crossover Trial to Evaluate the Efficacy and Safety of Atomoxetine in Adults With Melanocortin Obesity Syndrome","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07304102","publication_url":"https://clinicaltrials.gov/study/NCT07304102","title":"Assessment of GORE® EXCLUDER® IBE Plus Stent Graft Performance in Patients Undergoing Endovascular Iliac Revascularization","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07414992","publication_url":"https://clinicaltrials.gov/study/NCT07414992","title":"Neoadjuvant STereotActic Body Radiotherapy and Cemiplimab With or Without Fianlimab for Cisplatin-Ineligible or Cisplatin-Declining Patients With Muscle-Invasive Bladder Cancer (NeoSTAR Bladder)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07465757","publication_url":"https://clinicaltrials.gov/study/NCT07465757","title":"A Phase 2 Study of Alisertib in Combination With Paclitaxel in Patients With Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Puma Biotechnology, Inc.","sponsor_slug":"puma-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07727980","publication_url":"https://clinicaltrials.gov/study/NCT07727980","title":"Tissue Preservation in Immediate 1C Implants Using an Anatomical Prefabricated Healing Abutment","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792500","publication_url":"https://clinicaltrials.gov/study/NCT06792500","title":"Investigational Study of Glycerol Tributyrate in MELAS and LHON-Plus","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"George Washington University","sponsor_slug":"george-washington-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05402384","publication_url":"https://clinicaltrials.gov/study/NCT05402384","title":"Evaluation of Efficacy and Safety of D-galactose Supplementation in SLC35A2-CDG, a Disorder of Hypogalactosylation","has_exemption":false,"start_date":"2027-01-31","completion_date":"2028-03-31","has_results":false,"results_due":false,"sponsor_name":"Eva Morava-Kozicz","sponsor_slug":"eva-morava-kozicz","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03678025","publication_url":"https://clinicaltrials.gov/study/NCT03678025","title":"Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer","has_exemption":false,"start_date":"2018-09-24","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03947450","publication_url":"https://clinicaltrials.gov/study/NCT03947450","title":"Autologous Volar Fibroblast Injection Into the Stump Site of Amputees","has_exemption":false,"start_date":"2019-09-05","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03984448","publication_url":"https://clinicaltrials.gov/study/NCT03984448","title":"Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas","has_exemption":false,"start_date":"2019-10-22","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03772028","publication_url":"https://clinicaltrials.gov/study/NCT03772028","title":"Phase III Randomized Clinical Trial for Stage III Epithelial Ovarian Cancer Randomizing Between Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy","has_exemption":false,"start_date":"2020-01-01","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"The Netherlands Cancer Institute","sponsor_slug":"the-netherlands-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752137","publication_url":"https://clinicaltrials.gov/study/NCT04752137","title":"Evaluation of Intraoperative Tumor Margin Identification With Fluorescent Dye Imaging","has_exemption":false,"start_date":"2022-05-25","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05764642","publication_url":"https://clinicaltrials.gov/study/NCT05764642","title":"Renal Microvessel Imaging for Characterization of Chronic Kidney Disease","has_exemption":false,"start_date":"2023-08-09","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06062875","publication_url":"https://clinicaltrials.gov/study/NCT06062875","title":"Effects of TNF Blockade on Human BPH/LUTS","has_exemption":false,"start_date":"2024-01-24","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Endeavor Health","sponsor_slug":"endeavor-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06073665","publication_url":"https://clinicaltrials.gov/study/NCT06073665","title":"Levothyroxine Dosing in Older Individuals","has_exemption":false,"start_date":"2024-01-31","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06350045","publication_url":"https://clinicaltrials.gov/study/NCT06350045","title":"Renal Puncture Above the Eleventh Rib (High Supracostal Approach) Versus Subcostal Puncture in Percutaneous Nephrolithotomy for Treatment of Renal Stones in Adults: A Prospective Randomized Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07212062","publication_url":"https://clinicaltrials.gov/study/NCT07212062","title":"A Phase II, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Sfatey and Tolerability of X/T+X-EC vs. Placebo in Participants With Alzheimer's Disease Currently Treated With Lecanemab.","has_exemption":false,"start_date":"2025-12-01","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Neurology Office of South Florida","sponsor_slug":"neurology-office-of-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961084","publication_url":"https://clinicaltrials.gov/study/NCT06961084","title":"Comparison of I-124 PET/CT to I-123 Whole Body Imaging for the Diagnosis of Thyroid","has_exemption":false,"start_date":"2025-12-04","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Hope","sponsor_slug":"thomas-hope","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06853223","publication_url":"https://clinicaltrials.gov/study/NCT06853223","title":"A Randomized Trial of CCR5 Inhibition as a Complement to Lung Transplant Induction Immunosuppression","has_exemption":false,"start_date":"2025-12-07","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06150599","publication_url":"https://clinicaltrials.gov/study/NCT06150599","title":"Sacral Neuromodulation for the Treatment of Chronic Pelvic Pain","has_exemption":false,"start_date":"2026-01-27","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Corewell Health East","sponsor_slug":"corewell-health-east","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822010","publication_url":"https://clinicaltrials.gov/study/NCT06822010","title":"A Phase II Trial of SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)","has_exemption":false,"start_date":"2026-03-06","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339163","publication_url":"https://clinicaltrials.gov/study/NCT07339163","title":"Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval (ISI) for Adults With Recurrent Respiratory Papillomatosis (RRP)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553442","publication_url":"https://clinicaltrials.gov/study/NCT07553442","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Single Dose Study of the Efficacy, Pharmacodynamics, and Safety of ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran","has_exemption":false,"start_date":"2026-04-27","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571018","publication_url":"https://clinicaltrials.gov/study/NCT07571018","title":"Development and Pilot Evaluation of a Novel Mobile Health Intervention for Young Adult Tobacco Cessation","has_exemption":false,"start_date":"2026-06-07","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07492134","publication_url":"https://clinicaltrials.gov/study/NCT07492134","title":"Comparing Placebo Versus Antibiotics for Acute Uncomplicated Diverticulitis","has_exemption":false,"start_date":"2026-07-07","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285473","publication_url":"https://clinicaltrials.gov/study/NCT07285473","title":"Low-dose Naltrexone (LDN) for the Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Dose-Finding","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07714369","publication_url":"https://clinicaltrials.gov/study/NCT07714369","title":"Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache: A Prospective, Open-Label, Single-Arm, Interventional Pilot Study","has_exemption":false,"start_date":"2026-10-01","completion_date":"2028-04-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04568616","publication_url":"https://clinicaltrials.gov/study/NCT04568616","title":"Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)","has_exemption":false,"start_date":"2021-08-13","completion_date":"2028-04-02","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07224477","publication_url":"https://clinicaltrials.gov/study/NCT07224477","title":"A Phase 2, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V540A in Healthy Females 16 to 26 Years of Age","has_exemption":false,"start_date":"2026-07-20","completion_date":"2028-04-04","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05719441","publication_url":"https://clinicaltrials.gov/study/NCT05719441","title":"A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission","has_exemption":false,"start_date":"2024-08-19","completion_date":"2028-04-06","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06646276","publication_url":"https://clinicaltrials.gov/study/NCT06646276","title":"A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).","has_exemption":false,"start_date":"2025-02-25","completion_date":"2028-04-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06919965","publication_url":"https://clinicaltrials.gov/study/NCT06919965","title":"A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System Versus Investigator's Choice of Intravesical Chemotherapy in Participants With High-risk Non-muscle-invasive Bladder Cancer With Susceptible FGFR Alterations Who Had Received Intravesical Bacillus Calmette-Guérin (BCG)","has_exemption":false,"start_date":"2025-09-10","completion_date":"2028-04-06","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07149207","publication_url":"https://clinicaltrials.gov/study/NCT07149207","title":"Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors","has_exemption":false,"start_date":"2026-05-04","completion_date":"2028-04-07","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07202247","publication_url":"https://clinicaltrials.gov/study/NCT07202247","title":"A Phase II Randomized Study of Interventions for Metabolic Protection Against Cardiometabolic Toxicity During Androgen Deprivation Therapy (IMPACT-ADT)","has_exemption":false,"start_date":"2025-11-05","completion_date":"2028-04-09","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04789486","publication_url":"https://clinicaltrials.gov/study/NCT04789486","title":"Nano-SMART: An Adaptive Phase I-II Trial of AGuIX Gadolinium-based Nanoparticles With Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Centrally Located Lung Tumors and Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2021-05-27","completion_date":"2028-04-10","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06784726","publication_url":"https://clinicaltrials.gov/study/NCT06784726","title":"Odronextamab for Relapsed/Refractory Large B-Cell Lymphomas Before Definitive Lymphoma-Directed Therapies","has_exemption":false,"start_date":"2025-09-04","completion_date":"2028-04-10","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07537153","publication_url":"https://clinicaltrials.gov/study/NCT07537153","title":"Genicular Artery Embolization for Patients With Mild-To-Moderate Knee Osteoarthritis","has_exemption":false,"start_date":"2026-07-10","completion_date":"2028-04-10","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07231952","publication_url":"https://clinicaltrials.gov/study/NCT07231952","title":"A Phase II Study of Time-limited Combination of Pirtobrutinib, Venetoclax, and Rituximab in Treatment Naïve Patients With Waldenström's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) (PRoVen)","has_exemption":false,"start_date":"2025-11-11","completion_date":"2028-04-11","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260683","publication_url":"https://clinicaltrials.gov/study/NCT06260683","title":"A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-Cigarettes on Smoking Behavior","has_exemption":false,"start_date":"2024-04-10","completion_date":"2028-04-12","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668181","publication_url":"https://clinicaltrials.gov/study/NCT06668181","title":"Open-Label, Single-Arm Trial to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants From 2 to Less Than 18 Years of Age With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-Related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis","has_exemption":false,"start_date":"2025-03-11","completion_date":"2028-04-12","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07149857","publication_url":"https://clinicaltrials.gov/study/NCT07149857","title":"A Phase 2 Multicohort Trial to Further Characterize the Efficacy and Safety of Ciltacabtagene Autoleucel","has_exemption":false,"start_date":"2025-10-03","completion_date":"2028-04-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04573478","publication_url":"https://clinicaltrials.gov/study/NCT04573478","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function","has_exemption":false,"start_date":"2020-12-11","completion_date":"2028-04-14","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533644","publication_url":"https://clinicaltrials.gov/study/NCT06533644","title":"A Phase 2a Multicenter, Dose-Escalation and Dose Optimization Study of SYNC-T Therapy SV-102 for Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-05-29","completion_date":"2028-04-14","has_results":false,"results_due":false,"sponsor_name":"Syncromune, Inc.","sponsor_slug":"syncromune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07023432","publication_url":"https://clinicaltrials.gov/study/NCT07023432","title":"Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)","has_exemption":false,"start_date":"2025-11-17","completion_date":"2028-04-14","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04515836","publication_url":"https://clinicaltrials.gov/study/NCT04515836","title":"Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma","has_exemption":false,"start_date":"2021-02-19","completion_date":"2028-04-15","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04988386","publication_url":"https://clinicaltrials.gov/study/NCT04988386","title":"An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants With Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)","has_exemption":false,"start_date":"2021-10-27","completion_date":"2028-04-15","has_results":false,"results_due":false,"sponsor_name":"Eidos Therapeutics, a BridgeBio company","sponsor_slug":"eidos-therapeutics-a-bridgebio-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07156578","publication_url":"https://clinicaltrials.gov/study/NCT07156578","title":"A Long-Term, Open-Label Extension Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)","has_exemption":false,"start_date":"2025-11-10","completion_date":"2028-04-15","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227857","publication_url":"https://clinicaltrials.gov/study/NCT07227857","title":"A Phase Ib/II First-in-human, Multicentre, Open-label, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effect of Intrathecal S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy","has_exemption":false,"start_date":"2025-11-24","completion_date":"2028-04-15","has_results":false,"results_due":false,"sponsor_name":"Institut de Recherches Internationales Servier","sponsor_slug":"institut-de-recherches-internationales-servier","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03153449","publication_url":"https://clinicaltrials.gov/study/NCT03153449","title":"Multi-Center Clinical Evaluation of the ATTUNE Revision System in Complex Primary Total Knee Arthroplasty","has_exemption":false,"start_date":"2017-09-19","completion_date":"2028-04-17","has_results":false,"results_due":false,"sponsor_name":"DePuy Orthopaedics","sponsor_slug":"depuy-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05859568","publication_url":"https://clinicaltrials.gov/study/NCT05859568","title":"Baseline Performance and Fitting Parameters for Sonova Products","has_exemption":false,"start_date":"2023-04-17","completion_date":"2028-04-17","has_results":false,"results_due":false,"sponsor_name":"Advanced Bionics","sponsor_slug":"advanced-bionics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06973187","publication_url":"https://clinicaltrials.gov/study/NCT06973187","title":"A Phase 3, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","has_exemption":false,"start_date":"2025-09-04","completion_date":"2028-04-17","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07130903","publication_url":"https://clinicaltrials.gov/study/NCT07130903","title":"A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2025-09-10","completion_date":"2028-04-17","has_results":false,"results_due":false,"sponsor_name":"Barbara Ann Karmanos Cancer Institute","sponsor_slug":"barbara-ann-karmanos-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907615","publication_url":"https://clinicaltrials.gov/study/NCT06907615","title":"An Open-label, Multi-center, Global Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2025-06-09","completion_date":"2028-04-20","has_results":false,"results_due":false,"sponsor_name":"Shanghai Henlius Biotech","sponsor_slug":"shanghai-henlius-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06526793","publication_url":"https://clinicaltrials.gov/study/NCT06526793","title":"A Modular Phase 2, Single-arm, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Surovatamig (AZD0486) in Participants With Relapsed or Refractory (R/R) B-cell Non-Hodgkin Lymphoma (SOUNDTRACK-B)","has_exemption":false,"start_date":"2024-11-27","completion_date":"2028-04-21","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06788938","publication_url":"https://clinicaltrials.gov/study/NCT06788938","title":"Tarlatamab in Advanced DLL3-Expressing Tumors Including Neuroendocrine Neoplasms","has_exemption":false,"start_date":"2025-03-21","completion_date":"2028-04-24","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06911502","publication_url":"https://clinicaltrials.gov/study/NCT06911502","title":"A Phase 3, Multicenter, Randomized, Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) Vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy","has_exemption":false,"start_date":"2025-07-28","completion_date":"2028-04-24","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07571746","publication_url":"https://clinicaltrials.gov/study/NCT07571746","title":"A Phase 2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Surovatamig in Adults With Antibody-mediated Kidney Disease","has_exemption":false,"start_date":"2026-03-28","completion_date":"2028-04-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05536349","publication_url":"https://clinicaltrials.gov/study/NCT05536349","title":"Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)","has_exemption":false,"start_date":"2022-12-20","completion_date":"2028-04-25","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05939414","publication_url":"https://clinicaltrials.gov/study/NCT05939414","title":"An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease Recurrence in Adult Male Patients With Prostate-specific Membrane Antigen (PSMA) Positive Oligometastatic Prostate Cancer (OMPC)","has_exemption":false,"start_date":"2024-03-12","completion_date":"2028-04-25","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06433011","publication_url":"https://clinicaltrials.gov/study/NCT06433011","title":"The RAPID - PE Study: RESCUE Advanced Protocol Without ICU Stay and no Lytic Drip - for the Treatment of Pulmonary Embolism","has_exemption":false,"start_date":"2024-10-17","completion_date":"2028-04-25","has_results":false,"results_due":false,"sponsor_name":"Thrombolex, Inc.","sponsor_slug":"thrombolex-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04108624","publication_url":"https://clinicaltrials.gov/study/NCT04108624","title":"A Multimodality Approach to Minimal Residual Disease Detection to Guide Post-Transplant Maintenance Therapy in Multiple Myeloma (MRD2STOP)","has_exemption":false,"start_date":"2019-10-30","completion_date":"2028-04-26","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05519475","publication_url":"https://clinicaltrials.gov/study/NCT05519475","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of siRNA Gene Silencing for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Participants With Genetic Risk Factors","has_exemption":false,"start_date":"2023-02-09","completion_date":"2028-04-27","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07733765","publication_url":"https://clinicaltrials.gov/study/NCT07733765","title":"A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS 12 YEARS OF AGE AND OLDER WITH MODERATE ALOPECIA AREATA","has_exemption":false,"start_date":"2026-07-31","completion_date":"2028-04-27","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435429","publication_url":"https://clinicaltrials.gov/study/NCT06435429","title":"A Phase 3, Randomized, Open-label, Multicenter, Controlled Study to Evaluate the Efficacy and Safety of Zanidatamab in Combination With Physician's Choice Chemotherapy Compared to Trastuzumab in Combination With Physician's Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer Who Have Progressed on, or Are Intolerant to, Previous Trastuzumab Deruxtecan Treatment","has_exemption":false,"start_date":"2024-08-13","completion_date":"2028-04-28","has_results":false,"results_due":false,"sponsor_name":"Jazz Pharmaceuticals","sponsor_slug":"jazz-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07109219","publication_url":"https://clinicaltrials.gov/study/NCT07109219","title":"A Modular Phase I/II, Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of AZD4512 Monotherapy or in Combination With Anticancer Agent(s) in Participants With Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2025-11-12","completion_date":"2028-04-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07430605","publication_url":"https://clinicaltrials.gov/study/NCT07430605","title":"WearME-Pro Phase II: Remote Use Usability and Longitudinal Validation Study (Patch Form Factor)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-04-28","has_results":false,"results_due":false,"sponsor_name":"LASARRUS Clinic and Research Center","sponsor_slug":"lasarrus-clinic-and-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05974202","publication_url":"https://clinicaltrials.gov/study/NCT05974202","title":"Augmenting Cognitive-behavioral Therapy With rTMS of the Medial Prefrontal and Anterior Cingulate Cortices for the Treatment of Cocaine Use Disorder","has_exemption":false,"start_date":"2026-08-14","completion_date":"2028-04-28","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06071767","publication_url":"https://clinicaltrials.gov/study/NCT06071767","title":"A Phase I/IIa Randomized, Placebo-Controlled Trial of Conserved-Mosaic T-cell Vaccine in a Regimen With Vesatolimod and Broadly Neutralizing Antibodies in Adults Initiated on Suppressive Antiretroviral Therapy During Acute HIV-1","has_exemption":false,"start_date":"2024-04-01","completion_date":"2028-04-29","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06358872","publication_url":"https://clinicaltrials.gov/study/NCT06358872","title":"Azithromycine Pour la Vie Des Enfants au Niger II","has_exemption":false,"start_date":"2024-04-29","completion_date":"2028-04-29","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01760005","publication_url":"https://clinicaltrials.gov/study/NCT01760005","title":"A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease","has_exemption":false,"start_date":"2012-12-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02718001","publication_url":"https://clinicaltrials.gov/study/NCT02718001","title":"Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance After Mitral Valve Replacement With Transcatheter Device (MISCEND)","has_exemption":false,"start_date":"2015-02-06","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03128996","publication_url":"https://clinicaltrials.gov/study/NCT03128996","title":"A Phase I/II Trial of Reduced Intensity Conditioning and Familial HLA-Mismatched Bone Marrow Transplantation in Children With Non-Malignant Disorders","has_exemption":false,"start_date":"2017-03-20","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03777267","publication_url":"https://clinicaltrials.gov/study/NCT03777267","title":"Cereset Research Exploratory Study","has_exemption":false,"start_date":"2019-04-12","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04089059","publication_url":"https://clinicaltrials.gov/study/NCT04089059","title":"A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)","has_exemption":false,"start_date":"2020-01-10","completion_date":"2028-04-30","has_results":true,"results_due":false,"sponsor_name":"Endotronix, Inc.","sponsor_slug":"endotronix-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04561401","publication_url":"https://clinicaltrials.gov/study/NCT04561401","title":"Can Brain Stimulation Enhance Outcomes Associated With Intensive Rehabilitation for Youth With Chronic Pain?","has_exemption":false,"start_date":"2020-10-19","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Calgary","sponsor_slug":"university-of-calgary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04725474","publication_url":"https://clinicaltrials.gov/study/NCT04725474","title":"A Phase 1/2, FIH, Two-part, Open-label Clinical Trial of Intravenous (IV) Administration of CTL-002 Given as Monotherapy and/or in Combination With an Anti-PD-1 Checkpoint Inhibitor in Subjects With Advanced-stage, Relapsed/Refractory Solid Tumors (The \"GDFATHER\"-Trial: GDF-15 Antibody-mediaTed Human Effector Cell Relocation).","has_exemption":false,"start_date":"2020-12-09","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"CatalYm GmbH","sponsor_slug":"catalym-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752722","publication_url":"https://clinicaltrials.gov/study/NCT04752722","title":"A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment","has_exemption":false,"start_date":"2021-04-22","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"enGene, Inc.","sponsor_slug":"engene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04799470","publication_url":"https://clinicaltrials.gov/study/NCT04799470","title":"Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease - UNMC/Medtronic Collaborative Acute Feasibility Pilot","has_exemption":false,"start_date":"2021-05-10","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04862286","publication_url":"https://clinicaltrials.gov/study/NCT04862286","title":"OptIMMize-2: A Phase 3 Multicenter, Single-arm, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Risankizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Completed Participation in Study M19-977 (OptIMMize-1)","has_exemption":false,"start_date":"2021-07-24","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04899908","publication_url":"https://clinicaltrials.gov/study/NCT04899908","title":"A Double-blind, Phase II Randomized Study of Brain-directed Stereotactic Radiation With or Without AGuIX Gadolinium-based Nanoparticles in the Management of Brain Metastases at Higher Risk of Local Recurrence With Radiation Alone","has_exemption":false,"start_date":"2021-09-15","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05164172","publication_url":"https://clinicaltrials.gov/study/NCT05164172","title":"Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine","has_exemption":false,"start_date":"2021-12-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"H. Lundbeck A/S","sponsor_slug":"h-lundbeck-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05269394","publication_url":"https://clinicaltrials.gov/study/NCT05269394","title":"A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease","has_exemption":false,"start_date":"2021-12-22","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05356741","publication_url":"https://clinicaltrials.gov/study/NCT05356741","title":"A Phase 1, Multicenter, Open-Label, First-in-Human Study of the Safety and Pharmacokinetics of VIR-5818 Alone and in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers","has_exemption":false,"start_date":"2022-04-13","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Vir Biotechnology, Inc.","sponsor_slug":"vir-biotechnology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05321134","publication_url":"https://clinicaltrials.gov/study/NCT05321134","title":"Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery","has_exemption":false,"start_date":"2022-04-28","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05275192","publication_url":"https://clinicaltrials.gov/study/NCT05275192","title":"Utilization of a Videoscope to Improve Clinical Outcomes of Periodontal Regeneration. A Pilot Study","has_exemption":false,"start_date":"2022-05-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Illinois at Chicago","sponsor_slug":"university-of-illinois-at-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05243797","publication_url":"https://clinicaltrials.gov/study/NCT05243797","title":"Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4","has_exemption":false,"start_date":"2022-09-08","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"European Myeloma Network B.V.","sponsor_slug":"european-myeloma-network-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04922333","publication_url":"https://clinicaltrials.gov/study/NCT04922333","title":"Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery","has_exemption":false,"start_date":"2023-03-28","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04919629","publication_url":"https://clinicaltrials.gov/study/NCT04919629","title":"Randomized Phase 2 Trial of APL-2 With Pembrolizumab vs. APL-2 With Pembrolizumab and Bevacizumab vs. Bevacizumab Alone in Patients With Recurrent Ovarian Cancer and Persistent Malignant Effusion","has_exemption":false,"start_date":"2023-04-27","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05681299","publication_url":"https://clinicaltrials.gov/study/NCT05681299","title":"Effects of Administration of Growth Hormone, Without and With Liraglutide, on AgRP, Energy and Glucose Metabolism in Healthy and GH Deficient Humans","has_exemption":false,"start_date":"2023-05-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05840211","publication_url":"https://clinicaltrials.gov/study/NCT05840211","title":"A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) (HER2 IHC0 or HER2-low [IHC 1+, IHC 2+/ISH-]) Inoperable, Locally Advanced, or Metastatic Breast Cancer and Have Received Endocrine Therapy","has_exemption":false,"start_date":"2023-05-08","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05313243","publication_url":"https://clinicaltrials.gov/study/NCT05313243","title":"Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma","has_exemption":false,"start_date":"2023-07-10","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05540574","publication_url":"https://clinicaltrials.gov/study/NCT05540574","title":"Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism","has_exemption":false,"start_date":"2023-08-09","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06020716","publication_url":"https://clinicaltrials.gov/study/NCT06020716","title":"A Phase 4 Double Blinded Study With Two Different Interventions, Each With Two Arms, to Evaluate the Clinical Efficacy of Antibiotics and the Role of Microbiology, Immunology and Genetics in Children Aged 9-36 Months With Chronic Wet Cough.","has_exemption":false,"start_date":"2023-08-16","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Helse Stavanger HF","sponsor_slug":"helse-stavanger-hf","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05878860","publication_url":"https://clinicaltrials.gov/study/NCT05878860","title":"A Phase 1/2/3, Open-Label, Dose Escalation, Dose Expansion and Randomized, Controlled Study to Evaluate the Safety and Efficacy of ATSN-201 Gene Therapy in Subjects With RS1-Associated X-linked Retinoschisis (LIGHTHOUSE)","has_exemption":false,"start_date":"2023-08-22","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Atsena Therapeutics Inc.","sponsor_slug":"atsena-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05692635","publication_url":"https://clinicaltrials.gov/study/NCT05692635","title":"Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance in Non-Squamous Locally Advanced Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2023-08-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06092034","publication_url":"https://clinicaltrials.gov/study/NCT06092034","title":"Gene Therapy for Danon Disease: A Phase 2 Study Evaluating the Efficacy and Safety of Intravenously Administered Adeno-Associated Virus Serotype 9 (rAAV9) Vector Containing the Human LAMP2 Isoform B Transgene (RP-A501; AAV9.LAMP2B) in Male Patients With Danon Disease","has_exemption":false,"start_date":"2023-09-05","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Rocket Pharmaceuticals Inc.","sponsor_slug":"rocket-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05948540","publication_url":"https://clinicaltrials.gov/study/NCT05948540","title":"A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members, Veterans, and Non-Veteran Civilians With PTSD","has_exemption":false,"start_date":"2023-11-02","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06162611","publication_url":"https://clinicaltrials.gov/study/NCT06162611","title":"Generating Evidence to Improve Same-day Etonogestrel (ENG) Implant Insertion for Emergency Contraception","has_exemption":false,"start_date":"2023-11-06","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Lori Gawron","sponsor_slug":"lori-gawron","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05866419","publication_url":"https://clinicaltrials.gov/study/NCT05866419","title":"Safety and Performance of the ThecaFlex DRx™ System Port and Catheter for Chronic Intrathecal Access, Cerebrospinal Fluid (CSF) Aspiration, and DElivery of Nusinersen in Spinal Muscular Atrophy (SMA) Patients Resistant to Lumbar PunctuRE Trial (PIERRE)","has_exemption":false,"start_date":"2023-11-27","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Alcyone Therapeutics, Inc","sponsor_slug":"alcyone-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996627","publication_url":"https://clinicaltrials.gov/study/NCT05996627","title":"Randomized Phase II Study of Belumosudil vs. Placebo for Preemptive Treatment of Chronic Graft Versus Host Disease","has_exemption":false,"start_date":"2023-12-06","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05383742","publication_url":"https://clinicaltrials.gov/study/NCT05383742","title":"A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)","has_exemption":false,"start_date":"2023-12-07","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05822362","publication_url":"https://clinicaltrials.gov/study/NCT05822362","title":"Cannabidiol for Individuals at Risk for Alzheimer's Disease: A Randomized Placebo Controlled Trial","has_exemption":false,"start_date":"2024-01-19","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06312189","publication_url":"https://clinicaltrials.gov/study/NCT06312189","title":"Open-Label Study of Valbenazine for the Treatment of Chorea Associated With Huntington Disease in Canada","has_exemption":false,"start_date":"2024-04-24","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06340711","publication_url":"https://clinicaltrials.gov/study/NCT06340711","title":"Phase II Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in PD-L1-Negative or Immunotherapy-refractory Esophagogastric Adenocarcinoma","has_exemption":false,"start_date":"2024-04-25","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06346067","publication_url":"https://clinicaltrials.gov/study/NCT06346067","title":"A Randomized, Open-label Phase III Study in Patients With Previously Treated Unresectable or Metastatic NRAS Mutant Cutaneous Melanoma Comparing the Combination of Naporafenib + Trametinib to Physician's Choice of Therapy (Dacarbazine, Temozolomide or Trametinib Monotherapy) With a Dose Optimization lead-in [SEACRAFT-2]","has_exemption":false,"start_date":"2024-04-29","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Erasca, Inc.","sponsor_slug":"erasca-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05992831","publication_url":"https://clinicaltrials.gov/study/NCT05992831","title":"Transcranial Magnetic Stimulation for MCI: A Phase II Dose-Response Study","has_exemption":false,"start_date":"2024-06-18","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06411210","publication_url":"https://clinicaltrials.gov/study/NCT06411210","title":"Obesity Complicating Type 1 Diabetes in Young Adults: Physiology and Impact of GLP-1 Analogue Anti-obesity Treatment on Cardiometabolic Risk Factors","has_exemption":false,"start_date":"2024-07-16","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06439953","publication_url":"https://clinicaltrials.gov/study/NCT06439953","title":"Impact of Prophylactic Use of Irrisept Irrigation System for Spinal Instrumentation","has_exemption":false,"start_date":"2024-10-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Rhode Island Hospital","sponsor_slug":"rhode-island-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619990","publication_url":"https://clinicaltrials.gov/study/NCT06619990","title":"A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants With Moderate-To-Severe Active Ulcerative Colitis.","has_exemption":false,"start_date":"2024-10-10","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Xencor, Inc.","sponsor_slug":"xencor-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712420","publication_url":"https://clinicaltrials.gov/study/NCT06712420","title":"Neoadjuvant Chemotherapy Versus Upfront Surgery for Locally Advanced Resectable Gall Bladder Cancer : A Randomized Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Rajiv Gandhi Cancer Institute & Research Center, India","sponsor_slug":"rajiv-gandhi-cancer-institute-research-center-india","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06722755","publication_url":"https://clinicaltrials.gov/study/NCT06722755","title":"Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation","has_exemption":false,"start_date":"2025-01-15","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792539","publication_url":"https://clinicaltrials.gov/study/NCT06792539","title":"A Multi-Center, Prospective, Non-Randomized, Pivotal Trial Evaluating the Safety and Effectiveness of the Polymotion Hip Resurfacing System","has_exemption":false,"start_date":"2025-01-22","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"JointMedica Inc.","sponsor_slug":"jointmedica-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06788990","publication_url":"https://clinicaltrials.gov/study/NCT06788990","title":"A Multicenter, Randomized, Double-blind, Phase 2/3 Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1-positive, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2025-01-28","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Bicara Therapeutics","sponsor_slug":"bicara-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06724237","publication_url":"https://clinicaltrials.gov/study/NCT06724237","title":"A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients With Peripheral T Cell Lymphoma That Achieved a First Complete Remission (CR1) Following Induction Therapy (PTCL-STAT)","has_exemption":false,"start_date":"2025-01-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eastern Cooperative Oncology Group","sponsor_slug":"eastern-cooperative-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06767514","publication_url":"https://clinicaltrials.gov/study/NCT06767514","title":"A Randomized, Double-blinded, Multiregional Phase 3 Study of Ivonescimab Versus Pembrolizumab for the First-line Treatment of Metastatic Non-small Cell Lung Cancer in Patients Whose Tumors Demonstrate High PD-L1 Expression","has_exemption":false,"start_date":"2025-02-27","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Summit Therapeutics","sponsor_slug":"summit-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06859268","publication_url":"https://clinicaltrials.gov/study/NCT06859268","title":"A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Retatrutide Treatment in the Maintenance of Weight Reduction in Individuals With Obesity","has_exemption":false,"start_date":"2025-03-05","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858254","publication_url":"https://clinicaltrials.gov/study/NCT06858254","title":"Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism","has_exemption":false,"start_date":"2025-04-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Apeiron Research Center","sponsor_slug":"apeiron-research-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06866275","publication_url":"https://clinicaltrials.gov/study/NCT06866275","title":"Suramin for the Treatment of Autism Trial (STAT): A Randomized, Double Blind, Crossover Trial of KZ101 in a Male Pediatric Population With Autism Spectrum Disorder","has_exemption":false,"start_date":"2025-04-09","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Orange County","sponsor_slug":"childrens-hospital-of-orange-county","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06929286","publication_url":"https://clinicaltrials.gov/study/NCT06929286","title":"COMparative Prospective Assessment Through Clinically Integrated Randomized Trials Evaluating Intravesical Treatments: The COMPARE IT Trial","has_exemption":false,"start_date":"2025-04-11","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06931821","publication_url":"https://clinicaltrials.gov/study/NCT06931821","title":"Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial","has_exemption":false,"start_date":"2025-04-15","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06873581","publication_url":"https://clinicaltrials.gov/study/NCT06873581","title":"A Pivotal Study of Voro Urologic Scaffold for the Treatment of Post Prostatectomy Stress Urinary Incontinence (ARID II)","has_exemption":false,"start_date":"2025-04-18","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Levee Medical, Inc.","sponsor_slug":"levee-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06899711","publication_url":"https://clinicaltrials.gov/study/NCT06899711","title":"A Prospective Study to Evaluate the Protective Effects of External Cranial Prosthesis on Incidence of Sunken Flap Syndrome in Decompressive Craniectomy Patients","has_exemption":false,"start_date":"2025-04-26","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06921148","publication_url":"https://clinicaltrials.gov/study/NCT06921148","title":"The Utility of Silk Bioprotein as a Wound Dressing in Female-to-Male Double-Incision Mastectomy","has_exemption":false,"start_date":"2025-04-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06636136","publication_url":"https://clinicaltrials.gov/study/NCT06636136","title":"Transtibial Osseointegration Surgery Study (TOSS)","has_exemption":false,"start_date":"2025-05-20","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Walter Reed National Military Medical Center","sponsor_slug":"walter-reed-national-military-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06957704","publication_url":"https://clinicaltrials.gov/study/NCT06957704","title":"Evaluation of the Efficacy and Safety of Subcutaneous Ketamine in the Treatment of Depressive Episode With Suicidal Ideation and/or Behavior in Adolescents","has_exemption":false,"start_date":"2025-05-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Federal University of São Paulo","sponsor_slug":"federal-university-of-sao-paulo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06852365","publication_url":"https://clinicaltrials.gov/study/NCT06852365","title":"Resistant Starch Usage in Polycystic Ovary Syndrome: Impact on Cardiometabolic Dysfunction and the Gut Microbiome (CORS-PCOS)","has_exemption":false,"start_date":"2025-06-10","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06405607","publication_url":"https://clinicaltrials.gov/study/NCT06405607","title":"Psilocybin vs Ketamine for Alcohol Use Disorder","has_exemption":false,"start_date":"2025-06-12","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937086","publication_url":"https://clinicaltrials.gov/study/NCT06937086","title":"A Phase 3b, Randomized, Multicenter, Controlled Study of Mirikizumab and Placebo or Mirikizumab Concomitantly Administered With Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight","has_exemption":false,"start_date":"2025-06-26","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228078","publication_url":"https://clinicaltrials.gov/study/NCT07228078","title":"An Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Alzheimer's Disease (Study SNK01-AD02)","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"NKGen Biotech, Inc.","sponsor_slug":"nkgen-biotech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06556693","publication_url":"https://clinicaltrials.gov/study/NCT06556693","title":"Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy","has_exemption":false,"start_date":"2025-08-12","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Zoll Medical Corporation","sponsor_slug":"zoll-medical-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06982521","publication_url":"https://clinicaltrials.gov/study/NCT06982521","title":"A Phase 3 Open-Label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment With a CDK4/6 Inhibitor","has_exemption":false,"start_date":"2025-08-26","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Relay Therapeutics, Inc.","sponsor_slug":"relay-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011719","publication_url":"https://clinicaltrials.gov/study/NCT07011719","title":"A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma","has_exemption":false,"start_date":"2025-09-08","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07153471","publication_url":"https://clinicaltrials.gov/study/NCT07153471","title":"A Phase 3 Study to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Trial","has_exemption":false,"start_date":"2025-09-15","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06835400","publication_url":"https://clinicaltrials.gov/study/NCT06835400","title":"An Open-Label, Randomized, Two-stage Study to Determine Dose Optimization, Safety, and Noninferiority of Oral Paclitaxel + Encequidar Compared to IV Paclitaxel in Subjects With HER2 Negative Metastatic Breast Cancer","has_exemption":false,"start_date":"2025-09-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Health Hope Pharma","sponsor_slug":"health-hope-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06848140","publication_url":"https://clinicaltrials.gov/study/NCT06848140","title":"Using High Definition Transcranial Direct Current Stimulation to Treat Verbal Retrieval Deficits Secondary to Chronic Traumatic Brain Injury (STIM-CTBI)","has_exemption":false,"start_date":"2025-10-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06858787","publication_url":"https://clinicaltrials.gov/study/NCT06858787","title":"The Validity of a Continuous Glucose Monitor in Diagnosing Gestational Diabetes: A Pilot Study","has_exemption":false,"start_date":"2025-10-02","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219966","publication_url":"https://clinicaltrials.gov/study/NCT07219966","title":"A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Moderate-to-Severe Alcohol Use Disorder (RENEW-ALC-1)","has_exemption":false,"start_date":"2025-10-15","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219953","publication_url":"https://clinicaltrials.gov/study/NCT07219953","title":"A Phase 3, Multicenter, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Alcohol Use Disorder (RENEW-ALC-2)","has_exemption":false,"start_date":"2025-10-16","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219173","publication_url":"https://clinicaltrials.gov/study/NCT07219173","title":"A Phase 2, Multicenter, Randomized, Double-blind, 52-week Study, to Investigate the Efficacy and Safety of Brenipatide Compared With Placebo for the Treatment of Adult Participants With Uncontrolled Moderate to Severe Asthma","has_exemption":false,"start_date":"2025-10-22","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07089576","publication_url":"https://clinicaltrials.gov/study/NCT07089576","title":"A Prospective, Multi-center Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA in the Open Repair of Aortic Arch Aneurysms and Dissections","has_exemption":false,"start_date":"2025-11-04","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Artivion Inc.","sponsor_slug":"artivion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06734039","publication_url":"https://clinicaltrials.gov/study/NCT06734039","title":"Impact of Anatomy-Based Frequency (ABF) Allocations on Early Performance Outcomes in MED-EL Cochlear Implant Recipients","has_exemption":false,"start_date":"2025-11-10","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Med-El Corporation","sponsor_slug":"med-el-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07236606","publication_url":"https://clinicaltrials.gov/study/NCT07236606","title":"A Phase 3, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RGX 121 in Pediatric Participants With Neuronopathic MPS II (Hunter Syndrome)","has_exemption":false,"start_date":"2025-11-25","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Regenxbio Inc.","sponsor_slug":"regenxbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07244705","publication_url":"https://clinicaltrials.gov/study/NCT07244705","title":"An Open-label, Multicenter, Phase 1/2 Study Exploring the Safety and Efficacy of ABT-301 in Combination With Tislelizumab and Bevacizumab in Participants With Proficient Mismatch Repair (pMMR)/Non-Microsatellite Instability-High (Non-MSI-H) Locally Advanced or Metastatic Colorectal Cancer (mCRC)","has_exemption":false,"start_date":"2025-11-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Anbogen Therapeutics, Inc.","sponsor_slug":"anbogen-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116460","publication_url":"https://clinicaltrials.gov/study/NCT07116460","title":"Cost Effective Air Filtration Intervention and Particulate Matter Monitoring in Low-Income Housing to Reduce Asthma Morbidity","has_exemption":false,"start_date":"2026-01-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07125235","publication_url":"https://clinicaltrials.gov/study/NCT07125235","title":"Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) mHealth Randomized Controlled Hybrid Type I Effectiveness Implementation Trial","has_exemption":false,"start_date":"2026-02-09","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07051707","publication_url":"https://clinicaltrials.gov/study/NCT07051707","title":"A Multicenter, Randomized, Study to Evaluate Safety and Efficacy After Treatment With the dNerva Lung Denervation System in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (AIRFLOW-4)","has_exemption":false,"start_date":"2026-02-24","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Nuvaira, Inc.","sponsor_slug":"nuvaira-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03567824","publication_url":"https://clinicaltrials.gov/study/NCT03567824","title":"A Phase 2 Open Label Study of Magnesium L-Lactate Dihydrate (MLD10) 10 mEq Extended-Release Caplets Administered BID for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus Followed by a Blinded Random Off Phase","has_exemption":false,"start_date":"2026-03-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Pharmalyte Solutions LLC","sponsor_slug":"pharmalyte-solutions-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07457918","publication_url":"https://clinicaltrials.gov/study/NCT07457918","title":"COVE-4: A Phase 3, Open-Label, Long-Term Follow-Up Study to Evaluate the Safety and Efficacy of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)","has_exemption":false,"start_date":"2026-03-11","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Verrica Pharmaceuticals Inc.","sponsor_slug":"verrica-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07556523","publication_url":"https://clinicaltrials.gov/study/NCT07556523","title":"Patient Quality of Recovery After TAVR With Different Sedation Regimens","has_exemption":false,"start_date":"2026-03-16","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"David Lyubashevsky","sponsor_slug":"david-lyubashevsky","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07465276","publication_url":"https://clinicaltrials.gov/study/NCT07465276","title":"Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable Squamous Cell Carcinoma of the Head and Neck: a Phase 2 Trial","has_exemption":false,"start_date":"2026-03-26","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06486181","publication_url":"https://clinicaltrials.gov/study/NCT06486181","title":"A Randomized Controlled Trial for Second Line Treatment of Acute DVT With Endovascular Interventional Treatments","has_exemption":false,"start_date":"2026-04-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07535437","publication_url":"https://clinicaltrials.gov/study/NCT07535437","title":"A Phase 1/2 Trial of Ivonescimab With Dato-DXd or Osimertinib in Patients With Metastatic EGFR-mutant Non-small Cell Lung Cancer That Progressed on EGFR TKI Therapy","has_exemption":false,"start_date":"2026-04-09","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07535463","publication_url":"https://clinicaltrials.gov/study/NCT07535463","title":"Safety and Efficacy of Ivonescimab and Chemotherapy Plus Stereotactic Radiosurgery (SRS) in the Treatment of Non-Small Cell Lung Cancer Brain Metastases","has_exemption":false,"start_date":"2026-04-10","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07660250","publication_url":"https://clinicaltrials.gov/study/NCT07660250","title":"Vagus Nerve Stimulation to Improve Post-operative Outcomes of Degenerative Cervical Myelopathy","has_exemption":false,"start_date":"2026-04-14","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07426458","publication_url":"https://clinicaltrials.gov/study/NCT07426458","title":"Ventilation and Perfusion in Individuals With Asthma","has_exemption":false,"start_date":"2026-04-27","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07278310","publication_url":"https://clinicaltrials.gov/study/NCT07278310","title":"STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"MiRus","sponsor_slug":"mirus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07456852","publication_url":"https://clinicaltrials.gov/study/NCT07456852","title":"Vasotoxicity Surveillance Using EndoPAT: The VASA Pilot Study","has_exemption":false,"start_date":"2026-04-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226453","publication_url":"https://clinicaltrials.gov/study/NCT07226453","title":"A Target Validation and Efficacy Study of Metformin in Patients With Recurrent or Progressive Posterior Fossa Group A (PFA) Ependymoma","has_exemption":false,"start_date":"2026-05-05","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07407582","publication_url":"https://clinicaltrials.gov/study/NCT07407582","title":"Phase I/II Open Label Trial of Intravenous Sodium Thiosulfate (Pedmark®) as Otoprotectant in Adults Receiving Cisplatin Chemotherapy (STOP-CIS)","has_exemption":false,"start_date":"2026-05-18","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07480356","publication_url":"https://clinicaltrials.gov/study/NCT07480356","title":"A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-Grade Non-Muscle Invasive Bladder Cancer","has_exemption":false,"start_date":"2026-05-29","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Protara Therapeutics","sponsor_slug":"protara-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07485803","publication_url":"https://clinicaltrials.gov/study/NCT07485803","title":"A Prospective, Randomized Trial Utilizing Methadone in the Management of Post-Operative Pain in Total Knee Replacement","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"AdventHealth","sponsor_slug":"adventhealth","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07544966","publication_url":"https://clinicaltrials.gov/study/NCT07544966","title":"Neurobiological Mechanisms of Susceptibility to Estradiol Fluctuation in Female Adolescents at Risk of Suicide: An Experimental Approach.","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07773688","publication_url":"https://clinicaltrials.gov/study/NCT07773688","title":"Expanded Two-photon Imaging of Skin Biopsy Specimens","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07530536","publication_url":"https://clinicaltrials.gov/study/NCT07530536","title":"Repetitive Transcranial Magnetic Stimulation for Enhancing Motor Recovery in Postoperative Brain Tumor Patients","has_exemption":false,"start_date":"2026-06-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Brian J.Gill","sponsor_slug":"brian-jgill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07612150","publication_url":"https://clinicaltrials.gov/study/NCT07612150","title":"An Exploratory Phase 2 Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Investigate the Safety, Tolerability, and Efficacy of TML-6 in Early Alzheimer's Disease","has_exemption":false,"start_date":"2026-08-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Merry Life Biomedical Co., Ltd.","sponsor_slug":"merry-life-biomedical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07520955","publication_url":"https://clinicaltrials.gov/study/NCT07520955","title":"Using Temporal Interference to Non-Invasively Enhance Sleep Homeostasis in Patients With Epilepsy","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07549022","publication_url":"https://clinicaltrials.gov/study/NCT07549022","title":"A Phase II Trial to Assess the Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor Patients With Homozygous MTAP Deletion","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Ankit Mangla, MD","sponsor_slug":"ankit-mangla-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07756294","publication_url":"https://clinicaltrials.gov/study/NCT07756294","title":"REstoring Vascular and Insulin Function To Augment Anti-Amyloid Therapy in ALZheimer'ss Disease (REVITAA-ALZ): A Placebo-controlled Trial of Intranasal Insulin vs. Empagliflozin in Mild Cognitive Impairment (MCI) or Early Alzheimer's Disease (AD) Treated With Anti-Amyloid Targeting Therapy (Lecanemab or Donanemab)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07761351","publication_url":"https://clinicaltrials.gov/study/NCT07761351","title":"A Randomized Controlled Trial Evaluating Lung Nodules - COMparing Percutaneous CT-Guided Biopsy And Shape-Sensing Robotic-Assisted Bronchoscopy (ENCOMPASS)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Intuitive Surgical","sponsor_slug":"intuitive-surgical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221825","publication_url":"https://clinicaltrials.gov/study/NCT07221825","title":"Low-Count Quantitative SPECT for Men Treated With Radium-223","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07146230","publication_url":"https://clinicaltrials.gov/study/NCT07146230","title":"The Selective Personalized Radio-Immunotherapy for Locally Advanced NSCLC Trial 2 (SPRINT 2)","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570953","publication_url":"https://clinicaltrials.gov/study/NCT07570953","title":"Effects Of Nocturnal Dronabinol Use On Obstructive Sleep Apnea Treatment And Physiological Outcomes","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07638566","publication_url":"https://clinicaltrials.gov/study/NCT07638566","title":"An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Activity of Empasiprubart in Adolescent Participants Aged 12 to Less Than 18 Years With Chronic Inflammatory Demyelinating Polyradiculoneuropathy","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07777718","publication_url":"https://clinicaltrials.gov/study/NCT07777718","title":"Nanotube Surface Architecture Versus Simple Titanium Coating on PEEK Interbody Cages in Adults Undergoing 1- and 2-Level Transforaminal Lumbar Interbody Fusion: A Randomized Controlled Superiority Trial","has_exemption":false,"start_date":"2026-09-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Francis Farhadi","sponsor_slug":"francis-farhadi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06615752","publication_url":"https://clinicaltrials.gov/study/NCT06615752","title":"A Phase I/II Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin With Docetaxel in Castration-resistant Prostate Cancer Patients","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Charles Drew University of Medicine and Science","sponsor_slug":"charles-drew-university-of-medicine-and-science","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07756489","publication_url":"https://clinicaltrials.gov/study/NCT07756489","title":"SECURE Post-Market Study (PMS): Atraumatic Sutureless Nerve Repair - Evaluation of COAPTIUM CONNECT in a REal-World Clinical Setting","has_exemption":false,"start_date":"2026-10-31","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"Tissium","sponsor_slug":"tissium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215403","publication_url":"https://clinicaltrials.gov/study/NCT07215403","title":"Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)","has_exemption":false,"start_date":"2026-11-30","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"AskBio Inc","sponsor_slug":"askbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06320951","publication_url":"https://clinicaltrials.gov/study/NCT06320951","title":"Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02802423","publication_url":"https://clinicaltrials.gov/study/NCT02802423","title":"A Multi-Center, Randomized, Double Blind, Placebo-Controlled, Phase IIA Study to Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid With Adjuvant Chemotherapy in Patients With Triple Negative Breast Cancer (TNBC) After Surgery","has_exemption":false,"start_date":"2027-01-01","completion_date":"2028-04-30","has_results":false,"results_due":false,"sponsor_name":"BioLite, Inc.","sponsor_slug":"biolite-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04274179","publication_url":"https://clinicaltrials.gov/study/NCT04274179","title":"A Prospective, Case-control Evaluation of Ketogenic Dietary Therapy for New-onset Childhood Absence Epilepsy","has_exemption":false,"start_date":"2020-08-10","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04906408","publication_url":"https://clinicaltrials.gov/study/NCT04906408","title":"The Effects of Post-Operative Interventions on Surgical Site Occurrences in Abdominal Wall Reconstructions: A Randomized Controlled Trial","has_exemption":false,"start_date":"2021-09-17","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05764395","publication_url":"https://clinicaltrials.gov/study/NCT05764395","title":"A Phase II Study to Evaluate the Safety and Efficacy of Rigosertib (ON 01910) Plus Pembrolizumab in Patients With Metastatic Melanoma Refractory to Immune Checkpoint Blockade","has_exemption":false,"start_date":"2023-05-09","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05899153","publication_url":"https://clinicaltrials.gov/study/NCT05899153","title":"Quantifying Patient-specific Changes in Neuromuscular Control in Cerebral Palsy: Adaptation and Biofeedback During Gait","has_exemption":false,"start_date":"2023-11-28","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06029309","publication_url":"https://clinicaltrials.gov/study/NCT06029309","title":"A Phase 1/2 Study of Zanubrutinib and Tafasitamab in Mantle Cell Lymphoma","has_exemption":false,"start_date":"2024-05-03","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Alvaro Alencar, MD","sponsor_slug":"alvaro-alencar-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06546670","publication_url":"https://clinicaltrials.gov/study/NCT06546670","title":"A Phase I/II Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ITU512 in Healthy Participants and Patients With Sickle Cell Disease","has_exemption":false,"start_date":"2024-08-15","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05154487","publication_url":"https://clinicaltrials.gov/study/NCT05154487","title":"Phase 2 Study of Alpelisib and Fulvestrant for PIK3CA-mutated Estrogen Receptor (ER)-Positive Endometrioid Endometrial Cancers","has_exemption":false,"start_date":"2024-09-11","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"GOG Foundation","sponsor_slug":"gog-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06831058","publication_url":"https://clinicaltrials.gov/study/NCT06831058","title":"A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)","has_exemption":false,"start_date":"2025-05-01","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06499285","publication_url":"https://clinicaltrials.gov/study/NCT06499285","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion-Dependent Anemia in Adult Participants With Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) (RENEW)","has_exemption":false,"start_date":"2025-05-06","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020312","publication_url":"https://clinicaltrials.gov/study/NCT07020312","title":"Brain-Computer Interface Visualization Training to Optimize Muscle Activation Following Orthopaedic Surgery: A Blinded Randomized Controlled Trial","has_exemption":false,"start_date":"2025-08-14","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06930651","publication_url":"https://clinicaltrials.gov/study/NCT06930651","title":"A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies","has_exemption":false,"start_date":"2025-09-03","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07172841","publication_url":"https://clinicaltrials.gov/study/NCT07172841","title":"Randomized Controlled Study on Non-invasive Diagnostics of Shunt Obstruction in Adult Hydrocephalus","has_exemption":false,"start_date":"2025-09-15","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Göteborg University","sponsor_slug":"goteborg-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209371","publication_url":"https://clinicaltrials.gov/study/NCT07209371","title":"Rifaximin Versus No Intervention in Patients With IgG/IgA (Non-IgM) Monoclonal Gammopathy of Undetermined Significance","has_exemption":false,"start_date":"2026-01-22","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024316","publication_url":"https://clinicaltrials.gov/study/NCT07024316","title":"A Phase I-II, N-of-1, Open-Label, Prospective Study to Evaluate the Efficacy and Safety of ATL-001 in Adult Patients With Congenital Erythropoietic Porphyria (CEP)","has_exemption":false,"start_date":"2026-01-29","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Atlas Molecular Pharma","sponsor_slug":"atlas-molecular-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07283900","publication_url":"https://clinicaltrials.gov/study/NCT07283900","title":"A Phase II Trial of High Dose Ascorbate in Combination With Azacitidine in Adults With Myelodysplastic Syndrome","has_exemption":false,"start_date":"2026-03-11","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Prajwal Dhakal","sponsor_slug":"prajwal-dhakal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567053","publication_url":"https://clinicaltrials.gov/study/NCT07567053","title":"6-Hz Primed Low and High-Frequency Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Children With Cerebral Palsy: TMS-EEG Study","has_exemption":false,"start_date":"2026-05-01","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Cook Children's Health Care System","sponsor_slug":"cook-childrens-health-care-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06193317","publication_url":"https://clinicaltrials.gov/study/NCT06193317","title":"Effects of taVNS on Fibromyalgia Pain","has_exemption":false,"start_date":"2026-06-01","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07635017","publication_url":"https://clinicaltrials.gov/study/NCT07635017","title":"Assessing the Effects of Hormones on Noninvasive Transcranial Stimulation","has_exemption":false,"start_date":"2026-07-01","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Carnegie Mellon University","sponsor_slug":"carnegie-mellon-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07482423","publication_url":"https://clinicaltrials.gov/study/NCT07482423","title":"A Phase I/II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of XVIE Injected Intradermally in Patients With Androgenetic Alopecia","has_exemption":false,"start_date":"2026-12-01","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Restore Biologics Holdings, Inc. dba Xtressé","sponsor_slug":"restore-biologics-holdings-inc-dba-xtresse","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07743138","publication_url":"https://clinicaltrials.gov/study/NCT07743138","title":"STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)","has_exemption":false,"start_date":"2027-02-07","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06049615","publication_url":"https://clinicaltrials.gov/study/NCT06049615","title":"The Conscious Sedation Single Arm Sub-Study","has_exemption":false,"start_date":"2027-08-01","completion_date":"2028-05-01","has_results":false,"results_due":false,"sponsor_name":"Conformal Medical, Inc","sponsor_slug":"conformal-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07583810","publication_url":"https://clinicaltrials.gov/study/NCT07583810","title":"A Phase II Study of the Non-Covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab in Patients With Marginal Zone Lymphoma","has_exemption":false,"start_date":"2026-12-16","completion_date":"2028-05-02","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07734649","publication_url":"https://clinicaltrials.gov/study/NCT07734649","title":"A Phase 1/2, Randomized, Controlled, Observer-Blind Study in Adults 60 Years of Age and Older to Evaluate the Immunogenicity and Safety of Different Dose Levels of a Bivalent Vaccine Candidate Against Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (HMPV)","has_exemption":false,"start_date":"2026-07-22","completion_date":"2028-05-03","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06574152","publication_url":"https://clinicaltrials.gov/study/NCT06574152","title":"Effect of Photobiomodulation on Pain and Healing of the Vertical Releasing Incision After Endodontic Microsurgery: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-08-20","completion_date":"2028-05-04","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07595549","publication_url":"https://clinicaltrials.gov/study/NCT07595549","title":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-MONTHLY PF-08653944 IN ADULTS WITH OVERWEIGHT OR OBESITY (VESPER-6)","has_exemption":false,"start_date":"2026-06-10","completion_date":"2028-05-04","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03701282","publication_url":"https://clinicaltrials.gov/study/NCT03701282","title":"A Randomized Phase III Study of the Addition of Venetoclax to Ibrutinib and Obinutuzumab Versus Ibrutinib and Obinutuzumab in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)","has_exemption":false,"start_date":"2019-02-12","completion_date":"2028-05-07","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06331312","publication_url":"https://clinicaltrials.gov/study/NCT06331312","title":"A Multi-center, Open-label Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Safety and Tolerability in Polymyalgia Rheumatica (PMR)","has_exemption":false,"start_date":"2024-06-28","completion_date":"2028-05-08","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05892068","publication_url":"https://clinicaltrials.gov/study/NCT05892068","title":"Window of Opportunity Analysis of Pre-Operative Tucatinib for Surgically Resected HER2+ Brain Metastases: Understanding Mechanisms of Resistance","has_exemption":false,"start_date":"2023-05-09","completion_date":"2028-05-09","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445972","publication_url":"https://clinicaltrials.gov/study/NCT06445972","title":"A Phase 1/2 Open-Label, Umbrella Platform Design Study to Evaluate the Safety and Efficacy of Investigational Agents in Combination With Standard of Care Treatments as the Second-Line Treatment of Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma: Substudy 06D","has_exemption":false,"start_date":"2024-08-07","completion_date":"2028-05-09","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184996","publication_url":"https://clinicaltrials.gov/study/NCT07184996","title":"A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis.","has_exemption":false,"start_date":"2025-10-08","completion_date":"2028-05-09","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07421167","publication_url":"https://clinicaltrials.gov/study/NCT07421167","title":"A Phase 2 Open-label Study to Evaluate the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least One Treatment (VAY2EXPLORE)","has_exemption":false,"start_date":"2026-08-04","completion_date":"2028-05-09","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07584967","publication_url":"https://clinicaltrials.gov/study/NCT07584967","title":"Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of 2 Dose Levels of the Oral Ghrelin Receptor Agonist AC01 Over 12 Weeks in Patients With Chronic Advanced Heart Failure With Reduced Ejection Fraction (HFrEF)","has_exemption":false,"start_date":"2026-09-15","completion_date":"2028-05-09","has_results":false,"results_due":false,"sponsor_name":"AnaCardio AB","sponsor_slug":"anacardio-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05874635","publication_url":"https://clinicaltrials.gov/study/NCT05874635","title":"Use of Signos mHealth Platform in Participants With Non-Insulin Dependent Type 2 Diabetes: Weight and Blood Glucose","has_exemption":false,"start_date":"2023-05-11","completion_date":"2028-05-10","has_results":false,"results_due":false,"sponsor_name":"Signos Inc","sponsor_slug":"signos-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06136650","publication_url":"https://clinicaltrials.gov/study/NCT06136650","title":"MK-5684-004: A Phase 3, Randomized, Open-label Study of Opevesostat Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment With One Next-generation Hormonal Agent (NHA) (OMAHA-004)","has_exemption":false,"start_date":"2023-12-18","completion_date":"2028-05-10","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06414863","publication_url":"https://clinicaltrials.gov/study/NCT06414863","title":"Treatment Effects of Invisalign Palatal Expander System and Hyrax Palatal Expander - A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-05-10","completion_date":"2028-05-10","has_results":false,"results_due":false,"sponsor_name":"University of the Pacific","sponsor_slug":"university-of-the-pacific","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04064060","publication_url":"https://clinicaltrials.gov/study/NCT04064060","title":"A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials","has_exemption":false,"start_date":"2019-08-12","completion_date":"2028-05-12","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984523","publication_url":"https://clinicaltrials.gov/study/NCT06984523","title":"A Phase II Single-Arm Study of Craniospinal Irradiation With Linac Based Volumetric Modulated Arc Therapy (VMAT) for Patients With Leptomeningeal Metastasis","has_exemption":false,"start_date":"2025-05-14","completion_date":"2028-05-12","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07296055","publication_url":"https://clinicaltrials.gov/study/NCT07296055","title":"Evaluating the Utility of Endobronchial Valves in the Management of Tubercular and NTM (Non Tubercolar Micobacteriosis) Pulmonary Cavities","has_exemption":false,"start_date":"2026-01-12","completion_date":"2028-05-12","has_results":false,"results_due":false,"sponsor_name":"Azienda Ospedaliero-Universitaria Careggi","sponsor_slug":"azienda-ospedaliero-universitaria-careggi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07594522","publication_url":"https://clinicaltrials.gov/study/NCT07594522","title":"Phase II Study of Ivonescimab Consolidation After Photon or Proton SBRT for Patients With Early-Stage NSCLC (I-PRECISE)","has_exemption":false,"start_date":"2026-05-12","completion_date":"2028-05-12","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07210086","publication_url":"https://clinicaltrials.gov/study/NCT07210086","title":"Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)","has_exemption":false,"start_date":"2025-11-26","completion_date":"2028-05-13","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07054515","publication_url":"https://clinicaltrials.gov/study/NCT07054515","title":"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-05-14","has_results":false,"results_due":false,"sponsor_name":"Azafaros B.V.","sponsor_slug":"azafaros-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07082725","publication_url":"https://clinicaltrials.gov/study/NCT07082725","title":"18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-05-14","has_results":false,"results_due":false,"sponsor_name":"Azafaros B.V.","sponsor_slug":"azafaros-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05267821","publication_url":"https://clinicaltrials.gov/study/NCT05267821","title":"Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS (TRIPS)","has_exemption":false,"start_date":"2022-06-14","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05650359","publication_url":"https://clinicaltrials.gov/study/NCT05650359","title":"A Randomized and Controlled Study of the Use of Orthopulse Photobiomodulation for Acceleration of Orthodontic Tooth Movement With Fixed Appliances","has_exemption":false,"start_date":"2022-10-13","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"Biolux Technology GmbH","sponsor_slug":"biolux-technology-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04348747","publication_url":"https://clinicaltrials.gov/study/NCT04348747","title":"A Phase IIa Study of Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab in Patients With Asymptomatic Brain Metastasis From Triple Negative Breast Cancer (TNBC) or HER2+ Breast Cancer (HER2+BC) or Hormone Receptor Positive (HR+) Breast Cancer.","has_exemption":false,"start_date":"2022-12-19","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846671","publication_url":"https://clinicaltrials.gov/study/NCT06846671","title":"A Phase 3, Open-Label, Randomized Study of BGB-16673 Compared to Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab or Venetoclax Plus Rituximab Retreatment) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both BTK and BCL2 Inhibitors","has_exemption":false,"start_date":"2025-04-10","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"BeOne Medicines","sponsor_slug":"beone-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288190","publication_url":"https://clinicaltrials.gov/study/NCT07288190","title":"A Multisite, Open-label, Randomized Crossover Study Comparing Adherence to a Single Daily Dual Prevention Pill (DPP) Versus FTC/TDF and Combined Oral Contraception Separate Pill Dosing (2PR), Given for Pre-exposure Prophylaxis and Pregnancy Prevention in Women","has_exemption":false,"start_date":"2026-05-15","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"HIV Prevention Trials Network","sponsor_slug":"hiv-prevention-trials-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567040","publication_url":"https://clinicaltrials.gov/study/NCT07567040","title":"Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial","has_exemption":false,"start_date":"2026-05-27","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07609914","publication_url":"https://clinicaltrials.gov/study/NCT07609914","title":"A PHASE 4, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EFFECTIVENESS OF REDOSING OF RIMEGEPANT IN PARTICIPANTS 18 YEARS OF AGE OR OLDER FOR THE ACUTE TREATMENT OF MIGRAINE","has_exemption":false,"start_date":"2026-05-28","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06954987","publication_url":"https://clinicaltrials.gov/study/NCT06954987","title":"A Two Cohort, Randomized, Double-Blind, Placebo-Controlled, Phase II Multi-Center Signal-Finding Study of Venetoclax Combined With Reduced-Intensity Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation Then Venetoclax Maintenance in Adult Patients With Acute Myeloid Leukemia in First Complete Remission: A MyeloMATCH Sub-Study","has_exemption":false,"start_date":"2026-07-17","completion_date":"2028-05-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06076642","publication_url":"https://clinicaltrials.gov/study/NCT06076642","title":"Long-term Safety and Tolerability of TAK-881 in Subjects With Primary Immunodeficiency Diseases (PIDD)","has_exemption":false,"start_date":"2024-11-04","completion_date":"2028-05-16","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06100289","publication_url":"https://clinicaltrials.gov/study/NCT06100289","title":"An Open-Label, Phase 3 Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy","has_exemption":false,"start_date":"2025-01-22","completion_date":"2028-05-16","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07015983","publication_url":"https://clinicaltrials.gov/study/NCT07015983","title":"A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE (Including Lupus Nephritis) With Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants (Breakfree-SLE)","has_exemption":false,"start_date":"2025-07-14","completion_date":"2028-05-17","has_results":false,"results_due":false,"sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","sponsor_slug":"juno-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07357727","publication_url":"https://clinicaltrials.gov/study/NCT07357727","title":"A Phase 3, Randomized, Double-blind, Active-control Study of Pelabresib (DAK539) and Ruxolitinib vs. Placebo and Ruxolitinib in Adult Patients With Myelofibrosis Who Are JAK Inhibitor Naive","has_exemption":false,"start_date":"2026-06-16","completion_date":"2028-05-17","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220785","publication_url":"https://clinicaltrials.gov/study/NCT07220785","title":"A Two-Part, Randomized, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Mibavademab in Patients With Generalized Lipodystrophy (LAGO)","has_exemption":false,"start_date":"2026-03-13","completion_date":"2028-05-19","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07709819","publication_url":"https://clinicaltrials.gov/study/NCT07709819","title":"A Nanoscopic Second Look Into the Knee Joint, What Have We Learned?","has_exemption":false,"start_date":"2026-05-20","completion_date":"2028-05-20","has_results":false,"results_due":false,"sponsor_name":"Angelina Vera MD","sponsor_slug":"angelina-vera-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07044726","publication_url":"https://clinicaltrials.gov/study/NCT07044726","title":"Betadine vs Sterile Water for Periurethral Preparation Prior to Straight Catherization in the Clinic Setting: A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-06-30","completion_date":"2028-05-21","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05884333","publication_url":"https://clinicaltrials.gov/study/NCT05884333","title":"Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults","has_exemption":false,"start_date":"2023-05-22","completion_date":"2028-05-22","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06424288","publication_url":"https://clinicaltrials.gov/study/NCT06424288","title":"EASi-HF Preserved - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Symptomatic Heart Failure (HF: NYHA II-IV) and Left Ventricular Ejection Fraction (LVEF) ≥40%","has_exemption":false,"start_date":"2024-06-17","completion_date":"2028-05-22","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07662213","publication_url":"https://clinicaltrials.gov/study/NCT07662213","title":"A Randomized, Open-label, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Oral Semaglutide in Adults With Type 2 Diabetes Mellitus (Eluminate-2)","has_exemption":false,"start_date":"2026-07-06","completion_date":"2028-05-23","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07664553","publication_url":"https://clinicaltrials.gov/study/NCT07664553","title":"A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin (Eluminate-3)","has_exemption":false,"start_date":"2026-07-08","completion_date":"2028-05-23","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07511036","publication_url":"https://clinicaltrials.gov/study/NCT07511036","title":"PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma","has_exemption":false,"start_date":"2026-09-01","completion_date":"2028-05-24","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03581136","publication_url":"https://clinicaltrials.gov/study/NCT03581136","title":"Phase II Multi-center Trial Evaluating 5 Fraction S-PBI (Stereotactic Partial Breast Irradiation) for Early Stage Breast Cancer Using the GammaPod","has_exemption":false,"start_date":"2019-04-22","completion_date":"2028-05-25","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07142252","publication_url":"https://clinicaltrials.gov/study/NCT07142252","title":"Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus","has_exemption":false,"start_date":"2026-05-14","completion_date":"2028-05-25","has_results":false,"results_due":false,"sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","sponsor_slug":"national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07734870","publication_url":"https://clinicaltrials.gov/study/NCT07734870","title":"Tirzepatide for Treatment of CCCA","has_exemption":false,"start_date":"2026-09-15","completion_date":"2028-05-25","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04879862","publication_url":"https://clinicaltrials.gov/study/NCT04879862","title":"Inter-System Closed-Loop Control of Locomotor and Bladder Function in Individuals With Acute Spinal Cord Injury","has_exemption":false,"start_date":"2022-04-04","completion_date":"2028-05-28","has_results":false,"results_due":false,"sponsor_name":"Claudia Angeli","sponsor_slug":"claudia-angeli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145373","publication_url":"https://clinicaltrials.gov/study/NCT06145373","title":"An Open-label, Single-arm Treatment Study to Investigate the Safety and Tolerability of Switching From Emicizumab to Fitusiran Prophylaxis in Male Participants Aged ≥12 Years of Age With Severe Hemophilia A, With or Without Inhibitors","has_exemption":false,"start_date":"2024-03-01","completion_date":"2028-05-28","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625034","publication_url":"https://clinicaltrials.gov/study/NCT06625034","title":"Randomized Phase III Trial of Rapid-Plan Knowledge-Based Planning vs. Human-Driven Planning for Prostate Cancer Radiotherapy","has_exemption":false,"start_date":"2025-02-02","completion_date":"2028-05-28","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null}]}